--> --> -->
Press Release Description

Europe Veterinary Vaccines market is predicted to surge at a CAGR of 5.5% during (2021-26)

According to the MarkNtel Advisors' research report, "Europe Veterinary Vaccines Market Analysis, 2021," the market is likely to grow at a CAGR of 5.5% during 2021-26 due to the growing popularity of animal adoption among people, surging advancement in vaccines, and the outbreak of contagious diseases among cattle & sheep. Moreover, the introduction of supportive initiatives by the government, increasing awareness regarding animal healthcare practice, and several technological innovations in biotechnology are further likely to fuel the segment growth in the forecast period.

Key questions answered in the study

  1. What are the current and future trends in the European Veterinary Vaccines market?
  2. How has the market been evolving in terms of end-user demand and application areas?
  3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
  4. What are the key growth drivers and challenges for the European Veterinary Vaccines market?
  5. What is the customer orientation, purchase behavior, and expectations from the Europe Veterinary Vaccines market service providers across various countries?

Bovine Vaccine Holds the Substantial Market Share

Based on Animal Vaccine Type, Bovine Vaccine held a substantial market share in the European Veterinary Vaccine market in the previous year. Bovine tuberculosis is among the obstinate animal health challenges faced by England. Last year, around 27,000 cattle slaughtered while tackling the disease, causing considerable distress to farm communities. To deal with this, the government took different initiatives toward deploying a cattle vaccine by 2025 in England and Wales to tackle bovine tuberculosis. Apart from this, there were massive investments in research projects for detecting infection in cattle herds. Thus, this is likely to promulgate the demand for bovine vaccine in the forecast period.

"Europe Veterinary Vaccines Market Analysis, 2021" provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Veterinary Vaccines providers across the countries. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings. 

Bovine Disease Register Significant Growth

Bovine Disease is likely to register significant growth in the European Veterinary Vaccines market over the forecast period during 2021-26 due to rising incidents of Foot and Mouth disease among mammals, placing a threat to agricultural development and livestock production as the disease is highly contagious. Apart from this, bolstering government strategies to eliminate bovine tuberculosis (bTB) in England by 2038 is also likely to infuse a lucrative opportunity for the growth of the European Veterinary Vaccines market in the forecast period, reveals MarkNtel Advisors in their research report, "Europe Veterinary Vaccines Market Analysis, 2021."

According to MarkNtel Advisors, the major leading players in the European Veterinary Vaccines market are Merck & Co. Inc., Virbac SA, Elanco Animal Health, Ceva Sante Animale, Phibro Animal Health Corp., HIPRA, Zoetis Inc., Boehringer Ingelheim International GmbH, Neogen Corporation, etc.

Market Segmentation:

  1. By Animal Vaccine Type (Livestock Vaccines (Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Other Livestock Vaccines), Companion Animal Vaccines (Canine Vaccines, Feline Vaccines, Equine Vaccines))
  2. By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other (DNA Vaccines, Subunit Vaccines, Conjugate Vaccines))
  3. By Disease Type (Canine Disease (Distemper, Kennel cough (Parainfluenza), Parvovirus, Canine herpes, Lyme Disease, Rabies), Porcine Disease, Bovine Disease (Foot & mouth disease (FMD), Lumpy skin, Rotavirus, Coronavirus, E. Coli, Other), Poultry Disease (Infectious Bronchitis, Avian Influenza, Marek's Disease, Newcastle Disease, Salmonella), Aquaculture Disease (Streptococcosis, Vibrio, Aeromonas), Other Disease Type)
  4. By Country (The UK, Germany, France, Spain, Italy, Others)
  5. By Competitors (Merck & Co. Inc., Virbac SA, Elanco Animal Health, Ceva Sante Animale, Phibro Animal Health Corp., HIPRA, Zoetis Inc., Boehringer Ingelheim International GmbH, Neogen Corporation etc.)

Need Assistance?
100% Safe & Secure
Strongest encryption on the website to make your purchase safe and secure